GETINGE AB |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 210.8 SEK | -1.31% |
|
-0.38% | -5.35% |
| Apr. 11 | Getinge’s Covered Stent System Gets EU Medical Device Regulation Certification | MT |
| Apr. 04 | GETINGE : EPS cut (2023: +3.1%, 2024: -10.5%) |  |
Chart calendar Getinge AB
418871f1f875a149d.kJYe5lUiMeqBqJ-hZoWPOwOVwOpD33sluRSjXsknXaU.o8lmiWBradqs0N6YNLHKUjDWtZ4NixBQ30DqB49-Apam2G2VEGZfhbTjqw~afcd9205df563ced8f3ee6904238a276
Upcoming events on Getinge AB
Past events on Getinge AB
| 2024-03-18 | Pharma Congress |
| 2024-02-06 | Cell & Gene Therapy Innovation leaders summit |
| 2024-02-01 04:00 am | Q4 2023 Earnings Call |
| 2024-02-01 02:00 am | Q4 2023 Earnings Release |
| 2023-10-23 04:00 am | Q3 2023 Earnings Call |
| 2023-10-23 02:00 am | Q3 2023 Earnings Release |
| 2023-07-18 04:00 am | Q2 2023 Earnings Call |
| 2023-07-18 02:00 am | Q2 2023 Earnings Release |
| 2023-04-26 | Ex-dividend day for final dividend |
| 2023-04-26 05:30 am | Annual General Meeting |
| 2023-04-26 04:00 am | Q1 2023 Earnings Call |
| 2023-04-26 02:00 am | Q1 2023 Earnings Release |
| 2023-02-01 04:00 am | FY 2022 Earnings Call |
| 2023-02-01 02:00 am | FY 2022 Earnings Release |
| 2022-11-21 11:00 am | Business Update Call |
| 2022-10-19 04:00 am | Q3 2022 Earnings Call |
| 2022-10-19 02:00 am | Q3 2022 Earnings Release |
| 2022-07-19 04:00 am | Interim 2022 Earnings Call |
| 2022-07-19 02:00 am | Interim 2022 Earnings Release |
| 2022-06-14 01:00 pm | Business Update Call |
Past dividends on Getinge AB
| 2023-04-26 | Annual 4.25 SEK |
| 2022-04-26 | Annual 4 SEK |
| 2021-04-20 | Annual 3 SEK |
| 2020-06-28 | Annual 1.5 SEK |
| 2019-04-23 | Annual 1 SEK |
| 2018-04-26 | Annual 1.5 SEK |
| 2017-12-06 | 0 SEK |
| 2017-03-29 | Annual 2 SEK |
| 2016-03-30 | Annual 2.8 SEK |
| 2015-03-25 | 2.8 SEK |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 26 559 26 525 0.13% | 29 819 29 992 -0.58% | 27 049 27 386 -1.23% | 28 292 28 049 0.87% | 31 827 30 886 3.05% | 33 972 |
|
EBITDA Million SEK | Released Forecast Spread | 4 986 4 662 6.95% | 7 487 7 245 3.33% | 6 754 6 445 4.79% | 5 891 5 957 -1.11% | 5 574 5 861 -4.89% | 6 488 |
|
EBIT Million SEK | Released Forecast Spread | 2 813 2 546 10.51% | 5 261 4 959 6.09% | 4 939 4 516 9.36% | 4 096 4 163 -1.61% | 3 653 3 835 -4.74% | 4 311 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 1 909 1 808 5.61% | 4 485 4 416 1.57% | 4 188 4 196 -0.18% | 3 472 3 973 -12.6% | 3 343 3 461 -3.4% | 3 718 |
|
Net income Million SEK | Released Forecast Spread | 1 222 1 360 -10.13% | 3 239 3 192 1.48% | 2 970 2 958 0.41% | 2 491 2 836 -12.18% | 2 412 2 487 -3.02% | 2 683 |
|
EPS SEK | Released Forecast Spread | 4,48 4,64 -3.44% | 11,9 11,6 2.59% | 10,9 10,9 0.25% | 9,15 10,2 -10.53% | 8,86 9,09 -2.49% | 9,72 |
| Announcement Date | 30/01/20 | 28/01/21 | 28/01/22 | 01/02/23 | 01/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 7 987 8 145 -1.94% | 6 182 6 351 -2.66% | 6 670 6 807 -2.02% | 6 941 6 884 0.83% | 8 498 8 421 0.92% | 7 141 6 686 6.8% | 7 176 6 923 3.65% | 7 607 7 320 3.93% | 9 903 9 232 7.27% | 7 629 | 8 011 | 8 264 | 10 338 | 8 044 |
|
EBITDA Million SEK | Released Forecast Spread | 2 118 1 641 29.07% | 1 235 1 340 -7.84% | 1 350 1 284 5.11% | 1 579 1 435 10.03% | 1 727 1 763 -2.06% | 1 380 1 163 18.66% | 902 872 3.39% | 1 525 1 062 43.54% | 1 766 1 841 -4.09% | 1 219 | 1 381 | 1 658 | 2 262 | 1 457 |
|
EBIT Million SEK | Released Forecast Spread | 1 652 1 093 51.14% | 797 886 -10.06% | 913 825 10.67% | 1 121 981 14.31% | 1 265 1 288 -1.8% | 921 710 29.72% | 442 460 -3.9% | 1 047 801 30.79% | 1 243 1 342 -7.4% | 721 | 967 | 1 211 | 1 735 | |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 1 075 1 101 -2.34% | 749 839 -10.76% | 867 787 10.12% | 1 075 938 14.56% | 781 1 237 -36.87% | 826 656 25.82% | 305 355 -14.19% | 1 227 601 104.26% | 986 1 192 -17.31% | 542 | 680 | 910 | 1 505 | 810 |
|
Net income Million SEK | Released Forecast Spread | 771 766 0.68% | 534 587 -9.11% | 603 516 16.95% | 798 644 23.91% | 556 870 -36.08% | 586 450 30.36% | 214 253 -15.37% | 894 400 123.33% | 718 847 -15.25% | 388 | 516 | 672 | 1 101 | 570 |
|
EPS SEK | Released Forecast Spread | 2,83 3,07 -7.82% | 1,96 2,11 -7.26% | 2,21 1,89 16.98% | 2,93 2,79 5.03% | 2,04 -0,19 1194.3% | 2,15 1,65 30.36% | 0,79 0,62 26.94% | 3,28 1,47 122.89% | 2,64 3,11 -15.22% | 1,43 | 1,90 | 2,47 | 4,04 | 2,09 |
| Announcement Date | 28/01/22 | 26/04/22 | 19/07/22 | 19/10/22 | 01/02/23 | 26/04/23 | 18/07/23 | 23/10/23 | 01/02/24 | - | - | - | - | - |
More events
Past sector events for Getinge AB
| 2024-03-26 | SHANDONG WEIGAO ORTHOPAEDIC DEVICE CO., LTD: Q4 2023 Earnings Release |
| 2024-03-26 02:00 am | SKAN GROUP AG: Q4 2023 Earnings Release |
| 2024-03-24 | APT MEDICAL INC.: Q4 2023 Earnings Release |
| 2024-02-28 04:05 pm | ZIMVIE INC.: Q4 2023 Earnings Release |
| 2024-02-28 04:05 pm | INARI MEDICAL, INC.: Q4 2023 Earnings Release |
| 2024-02-27 04:05 pm | TREACE MEDICAL CONCEPTS, INC.: Q4 2023 Earnings Release |
| 2024-02-27 04:05 pm | MASIMO CORPORATION: Q4 2023 Earnings Release |
| 2024-02-26 04:09 pm | SI-BONE, INC.: Q4 2023 Earnings Release |
| 2024-02-22 04:05 pm | PENUMBRA, INC.: Q4 2023 Earnings Release |
| 2024-02-22 07:00 am | NOVOCURE LIMITED: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GETI B Stock
- Calendar Getinge AB
